Radioiodine therapy effectively treats hyperthyroidism and thyroid cancer by permanently destroying thyroid tissue. Most hyperthyroid patients achieve normal levels within 8 to 12 weeks, though 10% to 20% require a second dose. Cancer patients benefit from ablation of remaining malignant cells, significantly improving 3-year survival rates.
- Success rate: High efficacy cured 80% to 90% of hyperthyroidism cases with one single dose.
- Common outcome: Most patients develop permanent hypothyroidism requiring lifelong daily levothyroxine hormone replacement.
- Recovery window: Patients typically see metabolic stabilization and symptom relief within 6 to 12 weeks.
- Safety protocols: Expect 3 to 7 days of strict isolation to protect others from radiation.
Bookimed Expert Insight: Thailand's medical centers, such as JCI-accredited Bumrungrad International Hospital, provide specialized nuclear medicine infrastructure that rivals US facilities. While American patients often face long waits for specialized ablation rooms, Thai clinics manage high volumes efficiently. This expertise is reflected in their ability to offer these treatments at 83% less than the $11,500 US average.
Patient Consensus: Many patients experience significant weight gain of 10 to 20 pounds during the first 2 years. While physical symptoms improve quickly, persistent fatigue remains a common reality even after thyroid levels normalize.